SRC and central nervous system cancer: Indeed, the cell-penetrating peptide TAT-Cx43266–283 recapitulates the inhibition of Src promoted by Cx43 in astrocytes and in a broad spectrum of glioma models, including human glioma stem cells, in vitro and in vivo [39,40,41,42].